Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical)

v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical)
 6 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Convertible Notes Payable One [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Common stock issuable upon conversion, shares | shares 3,951,225
Common stock issuable upon conversion | $ $ 790,245
Common stock issuable upon conversion, price per share | $ / shares $ 0.20
Beneficial ownership limitations percentage 9.99%
Convertible Notes Payable Two [Member]  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Common stock issuable upon conversion, shares | shares 8,050,000
Common stock issuable upon conversion | $ $ 805,000
Common stock issuable upon conversion, price per share | $ / shares $ 0.10
Beneficial ownership limitations percentage 4.99%